Literature DB >> 11310693

A blinded comparison of three laboratory protocols for the identification of patients colonized with methicillin-resistant Staphylococcus aureus.

M Gardam1, J Brunton, B Willey, A McGeer, D Low, J Conly.   

Abstract

OBJECTIVE: To compare three laboratory screening protocols for the detection of methicillin-resistant Staphylococcus aureus (MRSA) from surveillance specimens (mannitol-salt agar containing 2 microg/mL of oxacillin [MSA-2], mannitol-salt agar containing 4 microg/mL of oxacillin [MSA-4], and a broth-containing protocol as recommended by the American Society for Microbiology [M-ASM]).
DESIGN: Blinded comparative laboratory study and cost analysis.
SETTING: University-affiliated microbiology laboratory.
METHODS: Outcome measurements included rate of detection of MRSA-positive specimens and patients, turnaround time, and media and technologist costs. All MRSA culture swabs obtained from any patient site from November 1998 to April 1999 were included.
RESULTS: The M-ASM protocol detected between 19.1% and 32.0% more MRSA-positive specimens and between 13.3% and 23.3% more MRSA-positive patients per surveillance event than the MSA-4 and MSA-2 protocols, respectively. There was no difference in positive-culture reporting time between the M-ASM and MSA4 protocols. The broth-containing protocol was 2- to 2.5-fold more expensive than the simpler protocols, taking into account media and laboratory personnel costs.
CONCLUSIONS: It remains to be determined whether it is cost beneficial for a hospital to adopt the M-ASM, as the potential cost of MRSA transmission from unidentified MRSA-colonized patients is unknown. A broth-containing protocol should be considered the gold standard in future studies examining newer MRSA screening protocols

Entities:  

Mesh:

Year:  2001        PMID: 11310693     DOI: 10.1086/501882

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  7 in total

1.  Evaluation of a new chromogenic medium, MRSA select, for detection of methicillin-resistant Staphylococcus aureus.

Authors:  Lisa Louie; Deirdre Soares; Helen Meaney; Mary Vearncombe; Andrew E Simor
Journal:  J Clin Microbiol       Date:  2006-10-18       Impact factor: 5.948

2.  Prospective Two-Center Comparison of Three Chromogenic Agars for Methicillin-Resistant Staphylococcus aureus Screening in Hospitalized Patients.

Authors:  Magali Dodémont; Carlo Verhulst; Claire Nonhoff; Carole Nagant; Olivier Denis; Jan Kluytmans
Journal:  J Clin Microbiol       Date:  2015-06-24       Impact factor: 5.948

3.  Evaluation of brilliance MRSA 2 agar for detection of methicillin-resistant Staphylococcus aureus in clinical samples.

Authors:  J Veenemans; C Verhulst; R Punselie; P H J van Keulen; J A J W Kluytmans
Journal:  J Clin Microbiol       Date:  2013-01-02       Impact factor: 5.948

4.  A double-blind, randomized, controlled trial of topical polysporin triple compound versus topical mupirocin for the eradication of colonization with methicillin-resistant Staphylococcus aureus in a complex continuing care population.

Authors:  S O'Grady; Z Hirji; B Pejcic-Karapetrovic; S Fung; H Dedier; J Takata-Shewchuk; K Zhang; J Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

5.  Comparison of culture screening methods for detection of nasal carriage of methicillin-resistant Staphylococcus aureus: a prospective study comparing 32 methods.

Authors:  Nasia Safdar; Leah Narans; Barbara Gordon; Dennis G Maki
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

6.  Methicillin-resistant Staphylococcus aureus: A public health issue with economic consequences.

Authors:  Mireille Goetghebeur; Pierre-Alexandre Landry; Donald Han; Colin Vicente
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-01       Impact factor: 2.471

7.  The epidemiology of Staphylococcus aureus carriage in patients attending inner city sexually transmitted infections and community clinics in Calgary, Canada.

Authors:  Alejandra Ugarte Torres; Angel Chu; Ron Read; Judy MacDonald; Daniel Gregson; Thomas Louie; Johanna Delongchamp; Linda Ward; Joann McClure; Kunyan Zhang; John Conly
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.